Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.80 |
| ▸ | DPP8 | Q6V1X1 | 14/20 | 0.80 |
| ▸ | DPP9 | Q86TI2 | 14/20 | 0.80 |
| ▸ | DPP7 | Q9UHL4 | 14/20 | 0.80 |
| ▸ | FAP | Q12884 | 10/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7298604 | 1.00 | DPP4 (0.80) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL27452954 | 1.00 | DPP4 (0.80) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL2182020 | 1.00 | DPP4 (0.80) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL2195630 | 1.00 | DPP4 (0.80) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5713150 | 1.00 | DPP4 (0.80) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL8501824 | 0.96 | DPP4 (0.74) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL2183274 | 0.91 | DPP4 (0.67) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL10792312 | 0.89 | DPP4 (0.67) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL6453066 | 0.89 | DPP4 (1.00) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7298573 | 0.87 | DPP4 (0.62) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105705034-A | Improved meat slurry methods of production and compositions | 微自然有限责任公司 | 2016-06-22 | — | — | CN | claimed |
| EP-1245568-B1 | Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV) | SERVIER LAB (FR) | 2006-01-18 | — | — | EP | claimed |
| US-6716843-B2 | INHIBITOR OF DIPEPTIDYL-PEPTIDASE IV | LES LABORATOIRES SERVIER (FR) | 2004-04-06 | — | — | US | claimed |
| US-20030087950-A1 | New alpha-amino acid sulphonyl compounds | LES LABORATOIRES SERVIER (FR) | 2003-05-08 | — | — | US | claimed |
| EP-0444898-A1 | Cyclic hexapeptide oxytocin antagonists | MERCK & CO. INC. (US) | 1991-09-04 | — | — | EP | claimed |
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-109879933-B | Phosphoryl-containing compound and application thereof | 河北科技大学 | 2023-06-06 | — | — | CN | disclosed |
| CN-109796519-B | Steroid compound and application thereof | 河北科技大学 | 2023-01-10 | — | — | CN | disclosed |
| CN-105705034-A | Improved meat slurry methods of production and compositions | 微自然有限责任公司 | 2016-06-22 | — | — | CN | disclosed |
| US-6716843-B2 | INHIBITOR OF DIPEPTIDYL-PEPTIDASE IV | LES LABORATOIRES SERVIER (FR) | 2004-04-06 | — | — | US | disclosed |
| US-6716843-B2 | INHIBITOR OF DIPEPTIDYL-PEPTIDASE IV | LES LABORATOIRES SERVIER (FR) | 2004-04-06 | — | — | US | disclosed |
| US-20040024180-A1 | Process for the production of 2,5 -diketopiperazines,2,5-diketopiperazines , dipeptides and their use thereof | DEGUSSA AG (DE) | 2004-02-05 | — | — | US | disclosed |
| US-20030087950-A1 | New alpha-amino acid sulphonyl compounds | LES LABORATOIRES SERVIER (FR) | 2003-05-08 | — | — | US | disclosed |
| US-20030087950-A1 | New alpha-amino acid sulphonyl compounds | LES LABORATOIRES SERVIER (FR) | 2003-05-08 | — | — | US | disclosed |
| EP-1274693-A1 | METHOD FOR PRODUCING 2,5-DIKETOPIPERAZINES, 2,5-DIKETOPIPERAZINES, DIPEPTIDES AND THE USE THEREOF | Degussa AG (DE) | 2003-01-15 | — | — | EP | disclosed |
| EP-1245568-A1 | Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV) | Les Laboratoires Servier (FR) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001081321-A1 | METHOD FOR PRODUCING 2,5-DIKETOPIPERAZINES, 2,5-DIKETOPIPERAZINES, DIPEPTIDES AND THE USE THEREOF | DEGUSSA AG (DE) | 2001-11-01 | — | — | WO | disclosed |
| US-4146614-A | TREATMENT OF SCHIZOPHRENIA | STATE OF MICHIGAN (US) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087950-A1 | New alpha-amino acid sulphonyl compounds | DNPEP, DPP4, DPP7 | DPP4 2/4885DPP8 5/4885DPP9 8/4885 |
| US-20040024180-A1 | Process for the production of 2,5 -diketopiperazines,2,5-diketopiperazines , dipeptides and their use thereof | DHPS, DPP7, VIP | DPP4 14/4885DPP8 73/4885DPP9 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.